FOLLOW US
COMMUNICATION
ROOM
.
Published: 2012-09-04 09:30
Business is good for ABIGO Medical AB
The expansive Swedish Gothenburg-based pharmaceutical company ABIGO Medical AB is benefiting from the debate concerning bacteria. In order to meet demand, SEK 10 million is being invested in the second half of 2012.
Business is good for the Gothenburg-based family-owned pharmaceutical company, ABIGO Medical AB. The company's Askersund factory is Sweden's only factory which produces advanced wound-healing products. The factory, which was opened in 2008 by Minister of Health and Social Affairs Göran Hägglund, is already in need of expansion. During the current half-year, the company is investing SEK 10 million in new machinery and an extension to the premises. The factory is currently working two shifts.
ABIGO Medical AB is a complete company with its own research and development, production and marketing. As the company is wholly owned by brothers Jan and Leif Smith, there is not considered to be any need for widespread publicity, and a long-term approach can be adopted to developing and growing the company.
The ability to treat wounds and fungal infections effectively without using antibiotics is an important aspect of the work relating to resistance development. ABIGO's unique patented Swedish wound-healing products represent an important contribution to this problem and are currently in use in 65 countries. A launch is currently under way in the USA. The products are based on the results of two senior Swedish professors and constitute an area within which ABIGO is continuing to research. The aim is to become a leading international company within the field and the company is already well on the way to achieving this aim. The unique products are effective, well-documented, have no known side-effects and no negative environmental impact. The company's research is cutting edge internationally and will result in new launches in the coming years.
ABIGO Medical AB is a complete company with its own research and development, production and marketing. As the company is wholly owned by brothers Jan and Leif Smith, there is not considered to be any need for widespread publicity, and a long-term approach can be adopted to developing and growing the company.
The ability to treat wounds and fungal infections effectively without using antibiotics is an important aspect of the work relating to resistance development. ABIGO's unique patented Swedish wound-healing products represent an important contribution to this problem and are currently in use in 65 countries. A launch is currently under way in the USA. The products are based on the results of two senior Swedish professors and constitute an area within which ABIGO is continuing to research. The aim is to become a leading international company within the field and the company is already well on the way to achieving this aim. The unique products are effective, well-documented, have no known side-effects and no negative environmental impact. The company's research is cutting edge internationally and will result in new launches in the coming years.
LATEST NEWS
New implant replaces damaged middle ear
2012-12-21
Hearing damage is the most common physical handicap in the industrialised world. People who are functionally deaf can now achieve normal hearing thanks to a new implant that...
Professor Jens Nielsen awarded by Nature
2012-12-20 Professor Jens Nielsen recieves the 2012 Nature Award for Mentoring in Science (Nordic countries) for his outstanding efforts to mentor young researchers. "Jens Nielsen is an...
Medfield Diagnostics: New MD takes office in January
2012-12-11 Dag Jungenfelt has been appointed as new Managing Director of Medfield Diagnostics from the 1st of January 2013.
Region Västra Götaland Delegation Visit to India
2012-12-11 Region Västra Götaland represented by Sahlgrenska International Care, Sahlgrenska University Hospital, Gothia Forum, Business Region Göteborg and the Unit for International...
108 business-to-business meetings between Swedish and French life science players at oncology seminar in Paris
2012-12-10 The three major Swedish life science regions (Gothenburg, Skåne and Stockholm) and the Paris Life Science cluster Medicen jointly organised a successful scientific business meeting...
2012-12-10 The three major Swedish life science regions (Gothenburg, Skåne and Stockholm) and the Paris Life Science cluster Medicen jointly organised a successful scientific business meeting...
CALENDAR
2013-06-10
Tel Aviv
IATI-BioMed 2013-06-17 Göteborg
Surgicon 2013 - 2nd World Congress on Surgical Training 2013-06-30 Visby, Sweden
Almedalsveckan 2013 / Almedalen Week 2013-09-12 Göteborg
Park Annual 13 2013-10-14 Stockholm
Nordic Life Science Days
IATI-BioMed 2013-06-17 Göteborg
Surgicon 2013 - 2nd World Congress on Surgical Training 2013-06-30 Visby, Sweden
Almedalsveckan 2013 / Almedalen Week 2013-09-12 Göteborg
Park Annual 13 2013-10-14 Stockholm
Nordic Life Science Days
LIFE SCIENCE-ORGANISATIONS
VACANT POSITIONS
Vacant positions within the biotech and life science area in the Göteborg region.
CURRENT CALLS
Here you find a list of current calls for proposals and applications for Life Science!
GöteborgBIO | Medicinaregatan 8A | SE-413 46 Göteborg, Sweden | Phone: +46 31 61 24 02 | E-mail: contact@goteborgbio.se